Toll‐like receptors (TLRs) are the important mediators of inflammatory pathways in the gut which play a major role in mediating the immune responses towards a wide variety of pathogen‐derived ligands and link adaptive immunity with the innate immunity. Numerous studies in different populations across the continents have reported on the significant roles of TLR gene polymorphisms in modulating the risk of colorectal cancer (CRC). CRC is one of the major malignancies affecting the worldwide population and is currently ranking the third most common cancer in the world. In this review, we have attempted to discuss the structure, functions, and signaling of TLRs in comprehensive detail together with the role played by various TLR gene SNPs in CRC susceptibility.
1 September 2022 in Biochemistry Research International
Writing an effective manuscript is one of the pivotal steps in the successful closure of the research project, and getting it published in a peer-reviewed and indexed journal adds to the academic profile of a researcher. Writing and publishing a scientific paper is a tough task that researchers and academicians must endure in staying relevant in the field. Success in translating the benchworks into the scientific content, which is effectively communicated within the scientific field, is used in evaluating the researcher in the current academic world. Writing is a highly time-consuming and skill-oriented process that requires familiarity with the numerous publishing steps, formatting rules, and ethical guidelines currently in vogue in the publishing industry. In this review, we have attempted to include the essential information that novice authors in their early careers need to possess, to be able to write a decent first scientific manuscript ready for submission in the journal of choice. This review is unique in providing essential guidance in a simple point-wise manner in conjunction with easy-to-understand illustrations to familiarize novice researchers with the anatomy of a basic scientific manuscript.
Cardiovascular disease (CVD) is a chronic pathological condition of the heart that is caused due to the deposition of the fats inside the artery that increases the chances of the clotting of blood. Numerous complications arising from the CVDs such as stroke, coronary heart disease, congenital heart disease or atherosclerotic heart disease, rheumatic heart disease, and peripheral arterial disease are reported around the world. Genetic polymorphisms, in distinct types of inflammatory molecule-coding genes, are one of the important factors increasing the risk of CVDs. Inflammation is the protective biological response to any type of injury, damage, and also an infection that is associated with pathogens. The molecules that take part in responding to any unfavorable condition of the body in the form of inflammation are known as inflammatory molecules. Many clinical-based epidemiological studies have reported that the variations in gene sequence, especially single nucleotide polymorphisms (SNPs), in various inflammatory molecule-coding genes are associated with CVD risk. In this chapter, we describe the general role of inflammatory molecules in CVDs and the role of SNPs in inflammatory molecule-coding genes (IL-1, IL-6, IL-10, TNF-α, TGF-β, and CRP) in the initiation and development of CVDs.
BACKGROUND: Glutathione-S-transferases (GSTs) are the most important phase II enzymes of the xenobiotic pathway responsible for the detoxification of carcinogens. GSTP1 gene polymorphisms are mostly associated with a lack or an alteration of enzymatic activity toward several substrates thus resulting in increased cancer susceptibility. GSTP1 promoter methylation is also frequently associated with tumor development or poor prognosis in a wide range of tumors. AIM: In this study, we examined the role of genetic polymorphism and promoter methylation of GSTP1 gene in the context of modulation of risk of colorectal cancer (CRC) in Kashmiri population. METHODS: This study used tissue tumor samples (114) and blood samples from (160) patients with CRC and 200 blood samples from healthy donors. GSTP1 polymorphism was studied using polymerase chain reaction (PCR)-restriction fragment length polymorphism and methylation using methylation-specific PCR. RESULTS: There was no significant association between GSTP1 I105V genotypes and the CRC (P>0.05). However, we found a significant association of the Val/Val variant genotype with the dwelling and smoking status (P-value < 0.05). Overall, the homozygous variant Val/Val genotype was associated with a modestly elevated risk for CRC (OR = 1.57; 95% CI = 0.67–3.57). Methyl-specific-PCR analysis revealed 25.4% methylation of the GSTP1 promoter in CRC cases and was not found to be statistically significantly associated with clinicopathological parameters of the CRC cases (P>0.05). Also, no significant associations of any of the three genotypes with promoter hypermethylation were observed. CONCLUSION: We conclude that promoter hypermethylation in homozygous GSTP1 mutants did not elevate the risk of CRC in Kashmiri population.
Human genome represents the entire DNA present in a viable human cell put together that contains all the information required to guide numerous life-sustaining cellular processes. The Human Genome Project (HGP) was undertaken mainly with the aim of establishing a reference genome deciphering, in detail, the basic structure, organization and function of all the genes present in the human genome, including the instructions required for the growth, development, function and survival of human beings. The HGP also revealed the highly conserved nature of human genome because of which all the humans share at least 99.5% sequence similarity and exhibit only a difference of around 0.1%–0.5%. This small difference between different genomes along with epigenetic modifications determines almost all the phenotypic diversity or differences that exist between any two individuals within and/or between populations. The genetic variations represent the variability that occurs in a human genome in comparison with other genomes and the reference genome established by the HGP. These genetic variations include two main types: the more commonly occurring genetic variations termed as genetic polymorphisms and the rare, less commonly occurring and often disease-causing genetic variations termed as mutations. Genetic polymorphism represents the most dynamic and most common form of genetic variations that occur in the human genome. It includes several major types of annotated genetic variations such as single nucleotide polymorphisms (SNPs),small indels, variable number of tandem repeats (VNTRs),short tandem repeats (STRs),copy number variations (CNVs; deletions or duplications),copy neutral variations (inversions and translocations) and transposable (mobile) element insertions. Genetic polymorphisms can directly lead to or may influence the phenotypic variations, including the difference in traits such as height; color of eyes, hair, and skin; and, and response to pathogens, chemicals, drugs and vaccines, and may modulate the susceptibility to or even cause various diseases including genetic disorders and multifactorial diseases. The methods or techniques used for the detection, analysis and characterization of genetic polymorphisms are diverse and dynamic. These techniques include several traditional techniques and their modifications that allow low- to medium-throughput detection and analysis and several other techniques including the new and emerging techniques such as next-generation sequencing (NGS)-based techniques that enable high-throughput detection and analysis of genetic variations.